share_log

Needham Maintains Buy on Veracyte, Lowers Price Target to $30

Needham Maintains Buy on Veracyte, Lowers Price Target to $30

Needham維持對Veracyte的買入,將目標價下調至30美元
Benzinga ·  2023/11/08 17:02

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $35 to $30.

尼德姆分析師邁克·馬特森維持Veracyte(納斯達克股票代碼:VCYT)的買入並將目標股價從35美元下調至30美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論